The latest closing stock price for VYNE Therapeutics as of November 08, 2024 is 3.16.
An investor who bought $1,000 worth of VYNE Therapeutics stock at the IPO in 2018 would have $-998 today, roughly -1 times their original investment - a -60.39% compound annual growth rate over 7 years.
The all-time high VYNE Therapeutics stock closing price was 2723.04 on March 28, 2018.
The VYNE Therapeutics 52-week high stock price is 4.48, which is 41.8% above the current share price.
The VYNE Therapeutics 52-week low stock price is 1.57, which is 50.3% below the current share price.
The average VYNE Therapeutics stock price for the last 52 weeks is 2.34.
An investor who bought $1,000 worth of VYNE Therapeutics stock at the IPO in 2018 would have $-998 today, roughly -1 times their original investment - a -60.39% compound annual growth rate over 7 years.
The all-time high VYNE Therapeutics stock closing price was 2723.04 on March 28, 2018.
The VYNE Therapeutics 52-week high stock price is 4.48, which is 41.8% above the current share price.
The VYNE Therapeutics 52-week low stock price is 1.57, which is 50.3% below the current share price.
The average VYNE Therapeutics stock price for the last 52 weeks is 2.34.